133 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
Rank Status Study
21 Not yet recruiting Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess
Condition: Furunculosis
Intervention: Biological: Antimicrobial TheraGauze
22 Recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
23 Recruiting Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis
Condition: Tinea Capitis
Intervention: Device: Dermoscopy
24 Recruiting Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation
Condition: Invasive Aspergillosis
Intervention:
25 Not yet recruiting Novel Biomarkers for Invasive Aspergillosis
Condition: Aspergillosis Invasive
Intervention: Procedure: blood sample
26 Not yet recruiting Radiolabelled IV and Oral Metabolism Study of F901318
Condition: Invasive Aspergillosis
Interventions: Drug: IV F901318;   Drug: Oral F901318
27 Not yet recruiting Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects
Condition: Invasive Aspergillosis
Interventions: Drug: F901318 Dose level A oral;   Drug: Placebo dose level A oral;   Drug: F901318 Dose level B oral;   Drug: Placebo dose level B oral;   Drug: F901318 Dose level C oral;   Drug: Placebo Dose level C oral
28 Recruiting Study of Potential for Interaction of Fluconazole With F901318
Condition: Invasive Aspergillosis
Interventions: Drug: F901318;   Drug: Fluconazole
29 Not yet recruiting A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945
Condition: Aspergillosis
Interventions: Drug: PC945 - single doses;   Drug: Placebo - single doses;   Drug: PC945 - repeat doses;   Drug: Placebo - repeat doses
30 Recruiting Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
31 Recruiting Exhaled Breath Analysis in the Early Detection of Aspergillosis
Condition: Invasive Aspergillosis
Intervention:
32 Not yet recruiting Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Sbv;   Drug: Miltefosine plus placebo;   Drug: Miltefosine plus GM-CSF
33 Not yet recruiting Predicting Visceral Leishmaniasis in HIV Infected Patients
Condition: Leishmaniasis, Visceral
Intervention: Other: No intervention
34 Recruiting Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Condition: Scabies
Interventions: Drug: Permethrin Cream, 5%;   Drug: Elimite
35 Recruiting A Study of a New Leishmania Vaccine Candidate ChAd63-KH
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: ChAd63-KH
36 Not yet recruiting Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies
Conditions: Gale;   Severe Forms of Scabies;   Oral Parasitic Drug;   Ivermectin
Interventions: Drug: Ivermectin 200 µg/kg;   Drug: Ivermectin 400 µg/kg
37 Recruiting Asymptomatic Leishmania Infection in HIV Patients
Condition: Visceral Leishmaniasis
Intervention:
38 Not yet recruiting Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Miltefosine
39 Recruiting Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Condition: Herpes Simplex
Intervention: Device: Vela Sentosa SA HSV1/2 Qualitative PCR Test
40 Not yet recruiting Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Topical Amphotericin-B 0.4% liposomal gel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.